| scholarly article | Q13442814 |
| P50 | author | Allen Steere | Q4731886 |
| William W Kwok | Q88664294 | ||
| Elise E Drouin | Q105913302 | ||
| William Klitz | Q30322458 | ||
| Gerald T Nepom | Q38546281 | ||
| P2093 | author name string | Ben A Falk | |
| Lee Ann Baxter-Lowe | |||
| P2860 | cites work | Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America | Q44628961 |
| HLA-DQ polymorphisms are highly selective for peptide binding interactions. | Q45082483 | ||
| Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus | Q45743039 | ||
| A comparison of two treatment regimens of ceftriaxone in late Lyme disease | Q46625674 | ||
| A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium | Q47625328 | ||
| Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis | Q47762137 | ||
| Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. | Q53881935 | ||
| Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. | Q54013765 | ||
| Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis | Q57158927 | ||
| Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices | Q57221639 | ||
| Treatment of lyme arthritis | Q59745819 | ||
| Case definitions for public health surveillance | Q64128816 | ||
| The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis | Q67567811 | ||
| Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles | Q70248294 | ||
| Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides | Q72070645 | ||
| Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi | Q73065110 | ||
| Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis | Q73313584 | ||
| Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi | Q22122357 | ||
| Lyme Disease | Q22250902 | ||
| Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis | Q22250914 | ||
| Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice | Q24550778 | ||
| HLA-DR2 subtypes form an additional supertypic family of DR beta alleles | Q24605420 | ||
| Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi | Q24642483 | ||
| A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi | Q28144621 | ||
| New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans | Q28207063 | ||
| Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group | Q28277088 | ||
| The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis | Q28306666 | ||
| Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis | Q30850806 | ||
| The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis | Q33999945 | ||
| Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease | Q34301091 | ||
| Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin | Q34560251 | ||
| Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation | Q35105901 | ||
| Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers | Q35294749 | ||
| Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region | Q35644176 | ||
| Elucidation of Lyme arthritis | Q35709662 | ||
| Cross-reactivity of T lymphocytes in infection and autoimmunity | Q35895561 | ||
| Juvenile rheumatoid arthritis and HLA: report of the Park City III workshop | Q36151780 | ||
| The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis | Q36364212 | ||
| cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally | Q36465640 | ||
| MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen | Q36733217 | ||
| Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis | Q41132275 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lyme disease | Q201989 |
| Lyme arthritis | Q1878727 | ||
| Borrelia burgdorferi | Q2723634 | ||
| P304 | page(s) | 961-71 | |
| P577 | publication date | 2006-04-17 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide | |
| P478 | volume | 203 |
| Q41782459 | A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule |
| Q39766269 | A high throughput MHC II binding assay for quantitative analysis of peptide epitopes. |
| Q36504045 | A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease |
| Q34069414 | An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design. |
| Q37365705 | Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis |
| Q34412483 | Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis |
| Q24627149 | Application of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetes |
| Q42139219 | Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis |
| Q50317575 | Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease. |
| Q90102145 | Biologic Markers of Antibiotic-Refractory Lyme Arthritis in Human: A Systematic Review |
| Q35070523 | Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease |
| Q34646554 | Borrelia burgdorferi arthritis-associated locus Bbaa1 regulates Lyme arthritis and K/B×N serum transfer arthritis through intrinsic control of type I IFN production |
| Q37157689 | Borreliosis: recent research, diagnosis, and management. |
| Q35071379 | C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells |
| Q36254472 | Design and analysis of immune-evading enzymes for ADEPT therapy. |
| Q92838361 | Differences in clinicopathologic variables between Borrelia C6 antigen seroreactive and Borrelia C6 seronegative glomerulopathy in dogs |
| Q36902069 | Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis. |
| Q35782984 | Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo. |
| Q26998992 | Forward genetic approaches for elucidation of novel regulators of Lyme arthritis severity |
| Q47684846 | Genetic Control of Lyme Arthritis by Borrelia burgdorferi Arthritis-Associated Locus 1 Is Dependent on Localized Differential Production of IFN-β and Requires Upregulation of Myostatin. |
| Q37361401 | HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination |
| Q39287326 | HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis |
| Q37998462 | Hamster and murine models of severe destructive Lyme arthritis. |
| Q37470590 | Human Lyme disease vaccines: past and future concerns. |
| Q36138254 | Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis |
| Q48251828 | IL-10 Deficiency Reveals a Role for TLR2-Dependent Bystander Activation of T Cells in Lyme Arthritis. |
| Q30353698 | Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice |
| Q37546409 | Immunogenetic Markers Definition in Latvian Patients with Lyme Borreliosis and Lyme Neuroborreliosis. |
| Q49586408 | Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis. |
| Q57537530 | Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience |
| Q91285149 | Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes |
| Q34296526 | Immunogenicity to biologics: mechanisms, prediction and reduction |
| Q55100972 | Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report. |
| Q42289978 | In Silico and In Vitro Analysis of Interaction between Ximelagatran and Human Leukocyte Antigen (HLA)-DRB1*07:01. |
| Q92730717 | In silico identification and modification of T cell epitopes in pertussis antigens associated with tolerance |
| Q42014200 | Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. |
| Q55667533 | Interaction of Nevirapine with the Peptide Binding Groove of HLA-DRB1*01:01 and Its Effect on the Conformation of HLA-Peptide Complex. |
| Q22252197 | Lyme Arthritis: Pathogenesis, Clinical Presentation, and Management |
| Q37001131 | Lyme arthritis: current concepts and a change in paradigm |
| Q29013670 | Lyme borreliosis |
| Q34573195 | Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut |
| Q36798614 | Lyme borreliosis--an update |
| Q84332803 | Lyme disease |
| Q24626864 | Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview |
| Q36850934 | Lyme disease and the orthopaedic implications of lyme arthritis |
| Q22252398 | Lyme disease: A rigorous review of diagnostic criteria and treatment |
| Q37738672 | Lyme disease: a review |
| Q38056621 | Lyme disease: aetiopathogenesis, factors for disease development and control. |
| Q30560471 | Lysosomal β-glucuronidase regulates Lyme and rheumatoid arthritis severity |
| Q28543006 | Mapping the Pareto optimal design space for a functionally deimmunized biotherapeutic candidate |
| Q36784433 | Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis |
| Q37690359 | Natural killer cells and natural killer T cells in Lyme arthritis |
| Q51897183 | Novel function of complement C3d as an autologous helper T-cell target. |
| Q33723303 | Partial pathogen protection by tick-bite sensitization and epitope recognition in peptide-immunized HLA DR3 transgenic mice. |
| Q34616781 | Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis |
| Q37417171 | Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment |
| Q36422052 | Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes |
| Q42573542 | Population Dynamics of Borrelia burgdorferi in Lyme Disease |
| Q58610324 | Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2 |
| Q35370734 | Prevention of lyme disease and other tick-borne infections |
| Q64266471 | Promiscuous CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine |
| Q30371474 | Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads |
| Q35019816 | Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis |
| Q38223310 | Review: unraveling Lyme disease |
| Q52695046 | Role of glutathione metabolism in host defense against Borrelia burgdorferi infection. |
| Q36642889 | Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis |
| Q28384290 | Spectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemia |
| Q30519448 | Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy |
| Q37556764 | T cell epitope: friend or foe? Immunogenicity of biologics in context |
| Q97644525 | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation-Updated Consensus and Review 2020 |
| Q39179342 | TLR-mediated B cell activation results in ectopic CLIP expression that promotes B cell-dependent inflammation |
| Q22242935 | The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America |
| Q38234946 | The Cross-Talk between Spirochetal Lipoproteins and Immunity |
| Q28548544 | The Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01 |
| Q83630386 | The amber theory of Lyme arthritis: initial description and clinical implications |
| Q37109534 | Tick-specific borrelial antigens appear to be upregulated in American but not European patients with Lyme arthritis, a late manifestation of Lyme borreliosis |
| Q34033207 | Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-responsive Lyme arthritis |
| Q26853072 | Tregitope update: mechanism of action parallels IVIg |
| Q30352021 | Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011. |
| Q57537584 | Use of Bioinformatics to Predict MHC Ligands and T-Cell Epitopes |
| Q33651558 | When a patient suspected with juvenile idiopathic arthritis turns out to be diagnosed with an infectious disease - a review of Lyme arthritis in children |
| Q36608155 | γδ T Cells and dendritic cells in refractory Lyme arthritis. |
Search more.